The World Athletics Council voted Thursday to ban athletes who are transgender women "or who have Differences of Sexual Development" from competing in elite track and field competitions.
The big picture: The new rule follows similar bans on transgender athletes competing in elite women's competitions, including swimming.
Federal health officials are continuing to investigate a multi-state outbreak of drug-resistant infections linked to eye drops.
Driving the news: At least 3 people have died and 68 people from 16 states were diagnosed with a rare strain of Pseudomonas aeruginosa in connection with the outbreak, according to the Centers for Disease Control and Prevention.
More than 4 in 10 U.S. adults are obese, with states in the South and Midwest showing some of the highest prevalence, a new analysis from NORC at the University of Chicago shows.
Why it matters: Obesity is associated with hypertension, cardiovascular disease, stroke and other conditions that are among the leading causes of preventable, premature death.
Driving the news: After years of complaints from transplant surgeons and patient advocates, the Biden administration is breaking up the monopoly held for nearly four decades by the non-profit United Network for Organ Sharing (UNOS).
Moderna CEO Stéphane Bancel would not commit during a Senate hearing Wednesday to reconsidering the decision to roughly quadruple the price of his company's COVID-19 vaccine once government purchases end.
The big picture: Ire over high health care costs is one of the few topics uniting Democrat and Republican lawmakers these days, and Moderna’s price hike has lawmakers concerned.
Food and Drug Administration advisers on Wednesday signaled openness to expediting an experimental drug from Biogen that targets a rare form of ALS, or Lou Gehrig's disease.
Why it matters: ALS is a progressive and fatal neurological disease that typically kills patients within three to five years of the first symptoms, and there are no approved therapies for this genetic form of the condition. The drug tofersen didn't achieve the main goal of a late-stage trial last year and carries the risk of serious side effects.
A U.S. District Court judge in Wyoming on Wednesday temporarily blocked a statewide abortion ban that came into effect over the weekend, according to multiple reports.
Driving the news: Judge Melissa Owens granted a restraining order due to a wider lawsuit challenging the state's new law that prohibits abortion at all stages of pregnancy except in cases of rape or incest, or to save a pregnant person's life, and another banning abortion pills that's due to take effect in July, per the New York Times.
How we carry ourselves doesn't just affect our bodies — it also touches our brains.
Why it matters: Slumped posture isn't just an aesthetic concern. It has wide-ranging effects on our well-being — both physical and mental.
"Bad" posture can look different for different people. Broadly, it refers to when your ears are out of alignment with the center of your body,Healthline notes.
The Biden administration is planning a major revamp of the nation's organ transplant system — including looking to break up the system that historically allocated kidneys, livers and other organs to patients.
The Biden administration on Tuesday rejected a request to use march-in rights to break the patent of the prostate cancer drug Xtandi as a way to lower the price.
Why it matters: The move is sure to lead to progressive pushback on the Hill.
Republicans itching to probe the pandemic response are already struggling to separate vaccine-related questions that could yield lessons learned from ones that echo theories experts say are debunked by reams of data.
Why it matters: Americans' trust in public health institutions has been shattered over the last few years. Scientists warn that although there's a lot that can be learned from good-faith inquiries, there's nothing positive that can come from using public health to score political points.
Nonprofit and public hospitals charged commercially insured patients up to 25% morefor brain scans with an MRI than for-profit facilities, a new JAMA analysis found.
Why it matters: It's one of the first comparisons using data from a Trump-era hospital price transparency law to show variations in what facilities negotiate with insurers for common services.
The Department of Homeland Security announced Tuesday night it's stepping up efforts to combat fentanyl trafficking across the Southern border with the launch of a major new, multi-agency operation.
Driving the news: "Operation Blue Lotus" has already "stopped more than 900 pounds of fentanyl from coming into the United States in its first week," per a DHS statement.
